Related Experiment Video

Updated: Jun 27, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination

Elaine M Castilow1, Steven M Varga

  • 1Interdisciplinary Graduate Program in Immunology, 51 Newton Road, 3-532 Bowen Science Building, University of Iowa, Iowa City, IA 52242.

Future Virology
|December 6, 2008
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in children. Mouse models reveal that T cells mediate immunopathology and vaccine-enhanced disease, crucial for developing safe RSV vaccines.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in young children.
  • Certain populations, including premature infants, the immunocompromised, and the elderly, face higher risks of severe RSV disease.
  • The lack of a safe and effective RSV vaccine stems partly from an incomplete understanding of vaccine-enhanced disease.

Purpose of the Study:

  • To review findings from mouse models of RSV vaccination.
  • To elucidate the role of virus-specific T cells in mediating immunopathology.
  • To understand the mechanisms behind RSV vaccine-enhanced disease.

Main Methods:

  • Analysis of data from established mouse models of RSV immunization.
  • Examination of the RSV-specific immune response, focusing on T cell populations.
  • Review of studies investigating immunopathology following RSV infection and vaccination.

Main Results:

  • Mouse models have been instrumental in studying RSV vaccine-enhanced disease.
  • Both CD4 and CD8 memory T cells are implicated in RSV-induced immunopathology.
  • T cells play a significant role in mediating severe disease after RSV infection and vaccination.

Conclusions:

  • Understanding T cell-mediated immunopathology is critical for developing safe and effective RSV vaccines.
  • Mouse models provide valuable insights into the complex immune responses to RSV and vaccination.
  • Further research into T cell function is necessary to overcome challenges in RSV vaccine development.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...